Disclosure 0001933414-26-000121-1

SEC FORM 4

$1,909,665.00

Mineralys Therapeutics, Inc. (MLYS)

Sale of 75,000 shares at $25.4622 per share.

Reporting Person Congleton Jon · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001933414-26-000121 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Mineralys Therapeutics, Inc. (MLYS)." Disclosed 2026-10-02. https://desqlong.com/cards/0001933414-26-000121-1 (retrieved 2026-10-03).